iiinova — where your digital self keeps evolving

wandalllab.bsky.social

@wandalllab.bsky.social

wandalllab.bsky.social @wandalllab.bsky.social · 13/10/2025

Launching the Copenhagen Center for Glycocalyx Research (CGR) at @UCPH! We study how cellular signals reshape the glycocalyx to power better diagnostics and targeted therapies—now joining forces with #JesperVelgaardOlsen at the Center for Protein Research. Grateful to #DNRF and our advisors!

010

wandalllab.bsky.social @wandalllab.bsky.social · 24/11/2024

We need to expand treatment options for more cancer patients! Excited to help drive innovation in cancer care with GO’s advanced glycopeptide platform, delivering next-gen clean targets to ADCs, CAR Ts, and bispecifics. pharma.h5mag.com/pharma_sep24...

pharma.h5mag.com

Era of ADCs: Pharma companies innovate to stand out in a buzzing market - Pharma Technology Focus | Issue 146 | September 2024

As antibody drug conjugate (ADC)-centred deals dominate the oncology space, biotechs are using newer targets and linkers to differentiate themselves.

000